CN1160098C - Medicine for treating myocardial infarction and angina pectoris - Google Patents
Medicine for treating myocardial infarction and angina pectoris Download PDFInfo
- Publication number
- CN1160098C CN1160098C CNB021089671A CN02108967A CN1160098C CN 1160098 C CN1160098 C CN 1160098C CN B021089671 A CNB021089671 A CN B021089671A CN 02108967 A CN02108967 A CN 02108967A CN 1160098 C CN1160098 C CN 1160098C
- Authority
- CN
- China
- Prior art keywords
- myocardial infarction
- medicine
- angina pectoris
- present
- treating myocardial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a medicine for dredging the heart and vessels, which is used for treating myocardial infarction and angina pectoris. Pure traditional Chinese medicine decoction pieces of american ginseng, notoginseng, leech, etc. are used for preparing two pure traditional Chinese medicine preparations of one prescription by a common method, and the preparations have the efficacy of dissolving thrombus, preventing coagulation, dispersing stasis, activating blood circulation, lowering oxygen consumption of cardiac muscle cells, obviously enhancing organism disease resistance, etc. Life quality of patients with myocardial infarction and angina pectoris can be effectively improved until clinical healing, and the present invention is an ideal medicine for treating myocardial infarction and angina pectoris.
Description
The present invention relates to a kind of treatment myocardial infarction, anginal medicine.Be raw material specifically with the natural Chinese medicines decoction pieces, the refining Chinese medicine preparation that is used for treating myocardial infarction, angina pectoris disease specially that forms.
Myocardial infarction, angina pectoris are that human sickness rate is the highest, the disease that mortality rate is the highest.And along with development of human society, the change of living environment, the quickening of rhythm of life, the increase of life stress, the sickness rate of myocardial infarction, angina pectoris disease is in rising trend.At present, a lot of to myocardial infarction, anginal Chinese medicine and western medicine, but all there are pros and cons in various degree to exist.
The object of the present invention is to provide a kind of easy to use, determined curative effect, thrombus dissolving, poly-, the invigorating the spleen and replenishing QI of anticoagulant effectively, the function that yin nourishing heart tonifying, repercussive are invigorated blood circulation makes human body recover normal new type natural pharmaceutical preparation.
Solution of the present invention is in the Bangkok, THA city this disease have been carried out field research, with theory of Chinese medical science this sick pathogeny has been carried out extensive discussion, and on the basis of a large amount of clinical trials, filter out have thrombolytic, natural drug decoction pieces such as anticoagulant is poly-, invigorating the spleen and replenishing QI, repercussive are invigorated blood circulation, kidney tonifying champion regulate yin-yang, form with conventional method is refining, capsule, injection formulation make its performance QI and blood regulating, thrombolytic-anticoagulant, invigorating the spleen and replenishing QI to reach effective treatment myocardial infarction and anginal purpose.
Medicine of the present invention is made by following component: Radix Panacis Quinquefolii (50g-100g), Radix Notoginseng (50g-80g), Radix Curcumae (30g-50g), Rhizoma Corydalis (30g-40g), Hirudo (20g-40g).
The formula optimization weight proportion scope of preparation medicine of the present invention is: Radix Panacis Quinquefolii (80g-100g), Radix Notoginseng (60g-80g), Radix Curcumae (30g-50g), Rhizoma Corydalis (20g-30g), Hirudo (20g-30g).
The optimum weight proportioning of preparation medicine of the present invention is: Radix Panacis Quinquefolii (100g), Radix Notoginseng (80g), Radix Curcumae (40g), Rhizoma Corydalis (30g), Hirudo (30g).
With above-mentioned each component medicine according to a conventional method, the present invention be can make and myocardial infarction, anginal medicine treated.
The present invention develops the pure Chinese medicinal preparation that is used for treating cardiovascular and cerebrovascular disease at me through the clinical practice of many decades.Process to myocardial infarction, anginal clinical observation, is guidance with the theory of Chinese medical science in the Bangkok, THA city, and based on clinical dialectical, through a large amount of clinical practices, constantly perfect improvement forms.Its characteristics are that it is the pure natural medical preparation, and determined curative effect has no side effect.Based on medicine of the present invention, cooperate other Therapeutic Method, treating both the principal and the secondary aspects of a disease at the same time can make myocardial infarction, angina pectoris, inaccessible arteria coronaria lead to again, improves coronary circulation, increase the supply of blood oxygen, prevent thrombosis, reduce the myocardial cell oxygen consumption, obviously improve body resistance against diseases, patient's clinical symptoms is improved rapidly, is a kind of comparatively ideal treatment myocardial infarction, anginal medicine.
Claims (2)
1, a kind of treatment myocardial infarction, anginal medicine is characterized in that it is to be made by the following weight proportion raw material:
Radix Panacis Quinquefolii 50g-100g Radix Notoginseng 50g-80g Radix Curcumae 30g-50g
Rhizoma Corydalis 30g-40g Hirudo 20g-40g.
2, treatment myocardial infarction according to claim 1, anginal medicine, wherein the weight proportion of each raw material is:
Radix Panacis Quinquefolii 100g Radix Notoginseng 80g Radix Curcumae 40g
Rhizoma Corydalis 30g Hirudo 30g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021089671A CN1160098C (en) | 2002-04-15 | 2002-04-15 | Medicine for treating myocardial infarction and angina pectoris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021089671A CN1160098C (en) | 2002-04-15 | 2002-04-15 | Medicine for treating myocardial infarction and angina pectoris |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1376491A CN1376491A (en) | 2002-10-30 |
| CN1160098C true CN1160098C (en) | 2004-08-04 |
Family
ID=4740423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021089671A Expired - Fee Related CN1160098C (en) | 2002-04-15 | 2002-04-15 | Medicine for treating myocardial infarction and angina pectoris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1160098C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843661B (en) * | 2009-09-25 | 2011-08-10 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating angina |
| CN101843720B (en) * | 2009-10-22 | 2011-07-20 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating angina |
| CN101843712B (en) * | 2009-10-28 | 2011-07-20 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating angina |
| CN101850034B (en) * | 2009-11-25 | 2011-08-10 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating angina |
| CN104510813B (en) * | 2015-01-10 | 2017-09-15 | 江西济民可信药业有限公司 | A kind of preparation method of heart maitong capsule |
-
2002
- 2002-04-15 CN CNB021089671A patent/CN1160098C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1376491A (en) | 2002-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1895620A (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN1160098C (en) | Medicine for treating myocardial infarction and angina pectoris | |
| CN100394963C (en) | Medicine for treating female chronic fatigue syndrome and its preparing process | |
| CN100544761C (en) | A kind of medicine for the treatment of coronary heart disease | |
| CN104906274A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN102988473A (en) | Chinese medicament for treating hypertension | |
| CN101897940A (en) | Formula of traditional Chinese medicine for antifatigue and preparation method thereof | |
| CN1049143C (en) | Traditional Chinese medicine for curing anemia | |
| CN108704042A (en) | Has effects that medicinal vesiculation preparation of reducing pressure and sugar and preparation method thereof | |
| CN102266528B (en) | Medicament for treating hypertension | |
| CN101181483B (en) | Chinese patent drug for curing cataptosis and hemiparalysis sequela | |
| CN1081076C (en) | Medicinal magnetic external-use paster | |
| CN105853635A (en) | Pharmaceutical composition for treating angina pectoris of coronary heart disease | |
| CN1305481C (en) | Preparation of moschus for refreshment | |
| CN109620947A (en) | U.S. face nti-freckle Chinese materia medica preparation | |
| CN103655917B (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease | |
| CN1413630A (en) | Medicine for treating over sexual intercourse, work at night, tired, poor memory, body hypoimmunity and endocrine function disturbance | |
| CN1068784C (en) | Diagnosis and treatment and health-care medicinal liquor of external use for the five sense organs | |
| CN104013732A (en) | Soft capsules for treating rheumatoid diseases | |
| CN116421699A (en) | Pharmaceutical composition for dysmenorrhea and preparation method thereof | |
| CN112245465A (en) | Foot bath powder for strengthening body resistance and benefiting qi | |
| CN108379483A (en) | It is a kind of to be used to treat medicament of child strabismus and preparation method thereof | |
| CN1500519A (en) | Medicinal liquor for treating rheumatism | |
| CN107596146A (en) | A kind of Chinese medicine compound prescription for treating coronary atherosclerosis and cerebrovascular sclerosis disease | |
| CN1745818A (en) | Pill for treating coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |